![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 15810-15815, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the A novel "weak toxin" (WTX) from Naja
kaouthia snake venom competes with
[125I]
"Weak Toxin" from Naja kaouthia Is a Nontoxic
Antagonist of
7 and Muscle-type Nicotinic Acetylcholine
Receptors*
,
,
,
Shemyakin-Ovchinnikov Institute of
Bioorganic Chemistry, Russian Academy of Sciences, 16/10
Miklukho-Maklaya Str., V-437 Moscow GSP-7, 117997 Russia, the
§ Department of Physiology, Centre Medical Universitaire, 1 Rue Michel Servet, 1211 Geneva 4, Switzerland, and ¶ Central
Research Biophysics, Bayer AG, D-51368 Leverkusen, Germany
-bungarotoxin for binding to the
membrane-bound Torpedo californica acetylcholine receptor
(AChR), with an IC50 of ~2.2 µM. In this respect, it is ~300 times less potent than neurotoxin II from Naja oxiana and
-cobratoxin from N. kaouthia, representing short-type and long-type
-neurotoxins,
respectively. WTX and
-cobratoxin displaced
[125I]
-bungarotoxin from the Escherichia
coli-expressed fusion protein containing the rat
7 AChR
N-terminal domain 1-208 preceded by glutathione
S-transferase with IC50 values of 4.3 and 9.1 µM, respectively, whereas for neurotoxin II the
IC50 value was >100 µM. Micromolar
concentrations of WTX inhibited acetylcholine-activated currents in
Xenopus oocyte-expressed rat muscle AChR and human and rat
7 AChRs, inhibiting the latter most efficiently
(IC50 of ~8.3 µM). Thus, a virtually
nontoxic "three-fingered" protein WTX, although differing from
-neurotoxins by an additional disulfide in the N-terminal loop, can
be classified as a weak
-neurotoxin. It differs from the
short chain
-neurotoxins, which potently block the muscle-type but
not the
7 AChRs, and is closer to the long
-neurotoxins, which
have comparable potency against the above-mentioned AChR types.
*
This work was supported by the Russian Foundation for Basic
Research (Grants 99-04-48798 and 00-04-48889) and by the Swiss National Science Foundation and the "Office Federal de l'Education et des Sciences." A preliminary account was presented at the XIIIth World Congress of the International Society on Toxinology,
September 18-22, 2000, Paris, France.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel. & Fax: 7 095 335 57 33; E-mail: vits@ibch.ru.
This article has been cited by other articles:
![]() |
V. Avramopoulou, A. Mamalaki, and S. J. Tzartos Soluble, Oligomeric, and Ligand-binding Extracellular Domain of the Human {alpha}7 Acetylcholine Receptor Expressed in Yeast: REPLACEMENT OF THE HYDROPHOBIC CYSTEINE LOOP BY THE HYDROPHILIC LOOP OF THE ACh-BINDING PROTEIN ENHANCES PROTEIN SOLUBILITY J. Biol. Chem., September 10, 2004; 279(37): 38287 - 38293. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Skok, E. N. Kalashnik, L. N. Koval, V. I. Tsetlin, Y. N. Utkin, J.-P. Changeux, and R. Grailhe Functional Nicotinic Acetylcholine Receptors Are Expressed in B Lymphocyte-Derived Cell Lines Mol. Pharmacol., October 1, 2003; 64(4): 885 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nirthanan, E. Charpantier, P. Gopalakrishnakone, M. C. E. Gwee, H.-E. Khoo, L.-S. Cheah, D. Bertrand, and R. M. Kini Candoxin, a Novel Toxin from Bungarus candidus, Is a Reversible Antagonist of Muscle (alpha beta gamma delta ) but a Poorly Reversible Antagonist of Neuronal alpha 7 Nicotinic Acetylcholine Receptors J. Biol. Chem., May 10, 2002; 277(20): 17811 - 17820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |